Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1464-1472

  Changyong, Li ^a   Xiangming, Jiang ^a   Lin, Yang ^a   Xihong, Liu ^a   Shi, Yue ^a   Liying, Li ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GREEN FLUORESCENT PROTEIN; HYDROXYPROLINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SURAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHIMERA; CHOLESTASIS; CONTROLLED STUDY; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 73549109212     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090037     Document Type: Article

References (44)

1. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669
2. Keeffe EB: Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001, 120:749-762
3. Kim WR, Ludwig J, Lindor KD: Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 2000, 95:1130-1138
4. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005, 115:209-218
5. Alvarez SE, Milstien S, Spiegel S: Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 2007, 18:300-307
6. Hannun YA, Obeid LM: Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008, 9:139-150
7. Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4:397-407
8. Billich A, Bornancin F, Devay P, Mechtcheriakova D, Urtz N, Baumruker T: Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 2003, 278:47408-47415
9. Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 2004, 92:913-922
10. Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M: Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-β1. Am J Respir Cell Mol Biol 2007, 37:395-404
11. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG: Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005, 309:1735-1739
12. Sekiguchi M, Iwasaki T, Kitano M, Kuno H, Hashimoto N, Kawahito Y, Azuma M, Hla T, Sano H: Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome. J Immunol 2008, 180:1921-1928
13. Serriere-Lanneau V, Teixeira-Clerc F, Li LY, Schippers M, de Wries W, Julien B, Tran-Van-Nhieu J, Manin S, Poelstra K, Chun J, Carpentier S, Levade T, Mallat A, Lotersztajn S: The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J 2007, 21:2005-2013
14. Kisseleva T, Brenner DA: Mechanisms of fibrogenesis. Exp Biol Med 2008, 233:109-122
15. Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR: A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004, 126:955-963
16. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, Forbes SJ: The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130:1807-1821
17. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, Brenner DA: Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006, 45:429-438
18. di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, Sanavio F, Cannito S, Zamara E, Bertero M, Davit A, Francica S, Novelli F, Colombatto S, Fagioli F, Parola M: Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57:223-231
19. Kallis YN, Alison MR, Forbes SJ: Bone marrow stem cells and liver disease. Gut 2007, 56:716-724
20. Annabi B, Thibeault S, Lee YT, Bousquet-Gagnon N, Eliopoulos N, Barrette S, Galipeau J, Beliveau R: Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Exp Hematol 2003, 31:640-649
21. Meriane M, Duhamel S, Lejeune L, Galipeau J, Annabi B: Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells. Stem Cells 2006, 24:2557-2565
22. Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, Henschler R: Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells 2007, 25:1966-1974
23. Xia JL, Dai CS, Michalopoulos GK, Liu YH: Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006, 168:1500-1512
24. Ezure T, Sakamoto T, Tsuji H, Lunz JG, Murase N, Fung JJ, Demetris AJ: The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 2000, 156:1627-1639
25. Uchinami H, Seki E, Brenner DA, D'Armiento J: Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006, 44:420-429
26. Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM: Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase l. Anal Biochem 2002, 303:167-175
27. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K: Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004, 40:1304-1311
28. Li LY, Grenard P, Van Nhieu JT, Julien B, Mallat A, Habib A, Lotersztajn S: Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 2003, 125:460-468
29. Spiegel S, English D, Milstien S: Sphingosine 1-phosphate signaling: providing cells with a direction. Trends Cell Biol 2002, 12:236-242
30. Ancellin N, Hla T: Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1. EDG-3, and EDG-5. J Biol Chem 1999, 274:18997-19002
31. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA, Waeber C: S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 2003, 469:125-134
32. Hla T, Venkataraman K, Michaud J: The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta 2008, 1781:477-482
33. Hla T: Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 2004, 15:513-520
34. Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y: Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 2000, 20:9247-9261
35. Jun DJ, Lee JH, Choi BH, Koh TK, Ha DC, Jeong MW, Kim KT: Sphingosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes. Endocrinology 2006, 147:5835-5844
36. 2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci 2007, 80:1768-1776
37. 2 receptor. Am J Resp Cell Mol Biol 2008, 39:356-363
38. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745
39. Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A: Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006, 24:1254-1264
40. Lebman DA, Spiegel S: Thematic review series: sphingolipids-cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J Lipid Res 2008, 49:1388-1394
41. 4-injured rats. J Hepatol 2006, 44:742-748
42. + mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004, 78:83-88
43. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I: Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006, 24:2292-2298
44. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouliere A: Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006, 38:135-151